InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
63,790.24
(
-0.71%
)
Post# of 46657
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bagheera

Send PM Follow Ignore
Followers 393
Posts 64207
Boards Moderated 3
Alias Born 08/20/2000

bagheera

Member Level

Re: None

Thursday, 03/08/2012 9:14:37 AM

Thursday, March 08, 2012 9:14:37 AM

Post# of 46657
XOMA news (Track Notes) XOMA Jumps on Positive Diabetes Treatment Study; Shares Add 8.1%
XOMA Jumps on Positive Diabetes Treatment Study; Shares Add 8.1%



09:07 AM EST, 03/08/2012 (MidnightTrader) -- XOMA (XOMA) is up 8.1% at $2.00 a
share before the bell after results of a study into XMetA, the company's
fully-human allosteric monoclonal antibody to the insulin receptor,
demonstrate that it has the potential to be a novel, long-acting agent for the
control of blood glucose levels in patients with diabetes.





THE STANDOFF

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up